Trial literature on hepatablastoma

Literature on hepatoblastoma trials

Search PubMed for recently published articles (external information service)
  1. Gödeke J, Luxenburger E, Trippel F, Becker K, Häberle B, Müller-Höcker J, von Schweinitz D, Kappler R: Low expression of N-myc downstream-regulated gene 2 (NDRG2) correlates with poor prognosis in hepatoblastoma. Hepatology international 2016, 10: 370 [PMID: 26646663] GOE2016
  2. Czauderna P, Haeberle B, Hiyama E, Rangaswami A, Krailo M, Maibach R, Rinaldi E, Feng Y, Aronson D, Malogolowkin M, Yoshimura K, Leuschner I, Lopez-Terrada D, Hishiki T, Perilongo G, von Schweinitz D, Schmid I, Watanabe K, Derosa M, Meyers R: The Children's Hepatic tumors International Collaboration (CHIC): Novel global rare tumor database yields new prognostic factors in hepatoblastoma and becomes a research model. European journal of cancer 2016, 52: 92 [PMID: 26655560] CZA2016
  3. Vokuhl C, Oyen F, Häberle B, von Schweinitz D, Schneppenheim R, Leuschner I: Small Cell Undifferentiated Hepatoblastomas (SCUD): All Malignant Rhabdoid Tumors? Genes, chromosomes & cancer 2016, [PMID: 27356182] VOK2016
  4. Ilmer M, Garnier A, Vykoukal J, Alt E, von Schweinitz D, Kappler R, Berger M: Targeting the Neurokinin-1 Receptor Compromises Canonical Wnt Signaling in Hepatoblastoma. Molecular cancer therapeutics 2015, 14: 2712 [PMID: 26516161] IIM2015
  5. Becker K, Furch C, Schmid I, von Schweinitz D, Häberle B: Impact of postoperative complications on overall survival of patients with hepatoblastoma. Pediatric blood & cancer 2015, 62: 24 [PMID: 25251521] BEC2015
  6. Trobaugh-Lotrario AD, Chaiyachati BH, Meyers RL, Häberle B, Tomlinson GE, Katzenstein HM, Malogolowkin MH, von Schweinitz D, Krailo M, Feusner JH: Outcomes for patients with congenital hepatoblastoma. Pediatric blood & cancer 2013, epub ahead of print [PMID: 23798361] TRO2013
  7. Schmid I, Häberle B, Albert MH, Corbacioglu S, Fröhlich B, Graf N, Kammer B, Kontny U, Leuschner I, Scheel-Walter HG, Scheurlen W, Werner S, Wiesel T, von Schweinitz D: Sorafenib and cisplatin/doxorubicin (PLADO) in pediatric hepatocellular carcinoma. Pediatric blood & cancer 2012, 58: 539 [PMID: 21922643] SCH2012c
  8. von Schweinitz D: Hepatoblastoma: recent developments in research and treatment. Seminars in pediatric surgery 2012, 21: 21 [PMID: 22248967] SCH2012b
  9. Kappler R, von Schweinitz D: A better way forward: targeting hedgehog signaling in liver cancer. Frontiers in bioscience 2012, 4: 277 [PMID: 22202060] KAP2012
  10. Goedeke J, Haeberle B, Schmid I, von Schweinitz D: 30. AFP Negative Cystic Liver Lesion in a Child Should Let One Think of Hepatoblastoma. J Pediatr Hematol Oncol 2011, 33:e245 [PMID: 21383638 ] GOE2011
  11. Grotegut S, Kappler R, Tarimoradi S, Lehembre F, Christofori G, Von Schweinitz D: Hepatocyte growth factor protects hepatoblastoma cells from chemotherapy-induced apoptosis by AKT activation. International journal of oncology 2010, 36: 1261 [PMID: 20372801] GRO2010
  12. Eichenmüller M, Gruner I, Hagl B, Häberle B, Müller-Höcker J, von Schweinitz D, Kappler R: Blocking the hedgehog pathway inhibits hepatoblastoma growth. Hepatology 2009, 49: 482 [PMID: 19177589] EIC2009a
  13. Hartmann W, Küchler J, Koch A, Friedrichs N, Waha A, Endl E, Czerwitzki J, Metzger D, Steiner S, Wurst P, Leuschner I, von Schweinitz D, Buettner R, Pietsch T: Activation of phosphatidylinositol-3'-kinase/AKT signaling is essential in hepatoblastoma survival. Clinical cancer research 2009, 15: 4538 [PMID: 19584164] HAR2009
  14. Eichenmüller M, von Schweinitz D, Kappler R: Betulinic acid treatment promotes apoptosis in hepatoblastoma cells. International journal of oncology 2009, 35: 873 [PMID: 19724925] EIC2009
  15. Zsíros J, Maibach R, Shafford E, Brugieres L, Brock P, Czauderna P, Roebuck D, Childs M, Zimmermann A, Laithier V, Otte JB, de Camargo B, MacKinlay G, Scopinaro M, Aronson D, Plaschkes J, Perilongo G: Successful treatment of childhood high-risk hepatoblastoma with dose-intensive multiagent chemotherapy and surgery: final results of the SIOPEL-3HR study. Journal of clinical oncology 2010, 28: 2584 [PMID: 20406943] ZSI2007
  16. Koch A, Waha A, Hartmann W, Hrychyk A, Schuller U, Waha A, Wharton KA Jr, Fuchs SY, von Schweinitz D, Pietsch T: Elevated expression of Wnt antagonists is a common event in hepatoblastomas. Clinical cancer research 2005, 11: 4295 [PMID: 15958610] KOC2005
  17. Otte JB, Pritchard J, Aronson DC, Brown J, Czauderna P, Maibach R, Perilongo G, Shafford E, Plaschkes J, International Society of Pediatric Oncology (SIOP): Otte JB, Pritchard J, Aronson DC, et al.: Liver transplantation for hepatoblastoma: results from the International Society of Pediatric Oncology (SIOP) study SIOPEL-1 and review of the world experience. Pediatr Blood Cancer 2004, 42: 74-83. [PMID: 14752798] OTT2004
  18. Koch A, Weber N, Waha A, Hartmann W, Denkhaus D, Behrens J, Birchmeier W, von Schweinitz D, Pietsch T: Mutations and elevated transcriptional activity of conductin (AXIN2) in hepatoblastomas. The Journal of pathology 2004, 204: 546 [PMID: 15538750] KOC2004
  19. Albrecht S, Hartmann W, Houshdaran F, Koch A, Gartner B, Prawitt D, Zabel BU, Russo P, Von Schweinitz D, Pietsch T: Allelic loss but absence of mutations in the polyspecific transporter gene BWR1A on 11p15. 5 in hepatoblastoma. International journal of cancer. Journal international du cancer 2004, 111: 627 [PMID: 15239143] ALB2004